English  |  正體中文  |  简体中文  |  总笔数 :0  
造访人次 :  51194588    在线人数 :  750
教育部委托研究计画      计画执行:国立台湾大学图书馆
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
关于TAIR

浏览

消息

著作权

相关连结

"tung hung su"的相关文件

回到依作者浏览
依题名排序 依日期排序

显示项目 31-80 / 193 (共4页)
1 2 3 4 > >>
每页显示[10|25|50]项目

机构 日期 题名 作者
臺大學術典藏 2021-03-09T01:47:46Z The clinical significance of occult hepatitis B transfusion in Taiwan - a look-back study TUNG-HUNG SU; Chen P.-J.; Chen T.-C.; Cheng H.-R.; Li L.; Lin K.-S.; Kao J.-H.; Chen D.-S.; Liu C.-J.
臺大學術典藏 2021-03-09T01:47:45Z Serum hepatitis B virus-DNA levels correlate with long-term adverse outcomes in spontaneous hepatitis B e antigen seroconverters Tseng T.-C.; Liu C.-J.; Chen C.-L.; Wang C.-C.; TUNG-HUNG SU; Kuo S.F.-T.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-03-09T01:47:45Z Determinants of spontaneous surface antigen loss in hepatitis B e antigen-negative patients with a low viral load Tseng T.-C.; Liu C.-J.; Yang H.-C.; TUNG-HUNG SU; Wang C.-C.; Chen C.-L.; Fang-Tzu Kuo S.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-03-09T01:47:45Z High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load Tseng T.-C.; Liu C.-J.; Yang H.-C.; TUNG-HUNG SU; Wang C.-C.; Chen C.-L.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-03-09T01:47:45Z Host genetic variants and hepatitis b virologic features in HBeAg-negative hepatitis B carriers with long-term biochemical remission Lin C.-L.; Tseng T.-C.; TUNG-HUNG SU; Liu C.-J.; Chen P.-J.; Lai M.-Y.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-03-09T01:47:44Z Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon-induced hepatitis B e antigen seroconversion Yang H.-C.; Chen C.-L.; Shen Y.-C.; Peng C.-Y.; Liu C.-J.; Tseng T.-C.; TUNG-HUNG SU; Chuang W.-L.; Yu M.-L.; Dai C.-Y.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-03-09T01:47:44Z Emerging hepatitis B virus infection in vaccinated populations: A rising concern? TUNG-HUNG SU; Chen P.-J.
臺大學術典藏 2021-03-09T01:47:44Z Young chronic hepatitis b patients with nucleos(t)ide analogue-induced hepatitis b e antigen seroconversion have a higher risk of HBV reactivation Tseng T.-C.; Liu C.-J.; TUNG-HUNG SU; Yang H.-C.; Wang C.-C.; Chen C.-L.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-03-09T01:47:43Z Host Genetic Factors Affecting Spontaneous HBsAg Seroclearance in Chronic Hepatitis B Patients Cheng H.-R.; Liu C.-J.; Tseng T.-C.; TUNG-HUNG SU; Yang H.-I.; Chen C.-J.; Kao J.-H.
臺大學術典藏 2021-03-09T01:47:43Z Serum hepatitis B surface antigen levels help predict disease progression in patients with low hepatitis B virus loads Tseng T.-C.; Liu C.-J.; Yang H.-C.; TUNG-HUNG SU; Wang C.-C.; Chen C.-L.; Hsu C.-A.; Fang-Tzu Kuo S.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-03-09T01:47:43Z Longitudinal Change of HBsAg in HBeAg-negative Patients with Genotype B or C Infection TUNG-HUNG SU; Liu C.-J.; Tseng T.-C.; Liu C.-H.; Yang H.-C.; Chen C.-L.; Chen P.-J.; Kao J.-H.; Chen D.-S.
臺大學術典藏 2021-03-09T01:47:43Z Viral load and alanine aminotransferase correlate with serologic response in chronic hepatitis B patients treated with entecavir Wang C.-C.; Tseng K.-C.; Peng C.-Y.; Hsieh T.-Y.; Lin C.-L.; TUNG-HUNG SU; Tseng T.-C.; Hsu C.-S.; Lin H.H.; Kao J.-H.
臺大學術典藏 2021-03-09T01:47:42Z Risk stratification of hepatocellular carcinoma in hepatitis B virus e antigen-negative carriers by combining viral biomarkers Tseng T.-C.; Liu C.-J.; Chen C.-L.; Yang H.-C.; TUNG-HUNG SU; Wang C.-C.; Yang W.-T.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-03-09T01:47:42Z Serum microRNA-122 level correlates with virologic responses to pegylated interferon therapy in chronic hepatitis C TUNG-HUNG SU; Liu C.-H.; Liu C.-J.; Chen C.-L.; Ting T.-T.; Tseng T.-C.; Chen P.-J.; Kao J.-H.; Chen D.-S.
臺大學術典藏 2021-03-09T01:47:42Z Milder clinical manifestation of scrub typhus in Kinmen, Taiwan TUNG-HUNG SU; Liu C.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-03-09T01:47:41Z Hepatitis B surface antigen level complements viral load in predicting viral reactivation in spontaneous HBeAg seroconverters Tseng T.-C.; Liu C.-J.; Yang W.-T.; Chen C.-L.; Yang H.-C.; TUNG-HUNG SU; Wang C.-C.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-03-09T01:47:41Z Pegylated interferon-α2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: A randomized trial Liu C.-H.; Huang C.-F.; Liu C.-J.; Dai C.-Y.; Liang C.-C.; Huang J.-F.; Hung P.-H.; Tsai H.-B.; Tsai M.-K.; Chen S.-I.; Lin J.-W.; Yang S.-S.; TUNG-HUNG SU; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; Yu M.-L.; Kao J.-H.
臺大學術典藏 2021-03-09T01:47:41Z Clinical significance and evolution of hepatic HBsAg expression in HBeAg-positive patients receiving interferon therapy TUNG-HUNG SU; Liu C.-J.; Yang H.-C.; Jeng Y.-M.; Cheng H.-R.; Liu C.-H.; Tseng T.-C.; Ling T.-Y.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-03-09T01:47:40Z Value of interleukin-28B genetic polymorphism on retreatment outcomes of chronic hepatitis C genotype 1 relapsers by peginterferon alfa plus ribavirin Chen M.-Y.; Liu C.-H.; Chen T.-C.; TUNG-HUNG SU; Chen P.-J.; Chen D.-S.; Kao J.-H.; Liu C.-J.
臺大學術典藏 2021-03-09T01:47:40Z Clinical and virological features of occult hepatitis B in patients with HBsAg seroclearance post-treatment or spontaneously Cheng H.-R.; Kao J.-H.; Wu H.-L.; Chen T.-C.; Tseng T.-C.; Liu C.-H.; TUNG-HUNG SU; Chen P.-J.; Chen D.-S.; Liu C.-J.
臺大學術典藏 2021-03-09T01:47:40Z Serum cytokine/chemokine profiles in acute exacerbation of chronic hepatitis B: Clinical and mechanistic implications Wu H.-L.; Kao J.-H.; Chen T.-C.; Wu W.-H.; Liu C.-H.; TUNG-HUNG SU; Yang H.-C.; Chen D.-S.; Chen P.-J.; Liu C.-J.
臺大學術典藏 2021-03-09T01:47:39Z Clinical significance of circulating miR-122 in patients with dual chronic hepatitis B and C virus infection Cheng H.-R.; Kao J.-H.; Wu H.-L.; Tseng T.-C.; Liu C.-H.; Yang H.-C.; TUNG-HUNG SU; Chen P.-J.; Chen D.-S.; Liu C.-J.
臺大學術典藏 2021-03-09T01:47:39Z Molecular mechanism and treatment of viral hepatitis-related liver fibrosis TUNG-HUNG SU; Kao J.-H.; Liu C.-J.
臺大學術典藏 2021-03-09T01:47:38Z HBV-DNA level at 6 months of entecavir treatment predicts HBeAg loss in HBeAg-positive chronic hepatitis B patients Peng C.-Y.; Hsieh T.-C.; Hsieh T.-Y.; Tseng K.-C.; Lin C.-L.; TUNG-HUNG SU; Tseng T.-C.; Lin H.H.; Wang C.-C.; Kao J.-H.
臺大學術典藏 2021-03-09T01:47:38Z Successful treatment of chronic hepatitis B and D with pegylated-interferon plus entecavir Chen G.-Y.; TUNG-HUNG SU; Kao J.-H.
臺大學術典藏 2021-03-09T01:47:38Z Serum biomarkers predictive of significant fibrosis and cirrhosis in chronic hepatitis B Lin C.-L.; Liu C.-H.; Wang C.-C.; Liang C.-C.; TUNG-HUNG SU; Liu C.-J.; Kao J.-H.
臺大學術典藏 2021-03-09T01:47:38Z Improving clinical outcomes of chronic hepatitis B virus infection TUNG-HUNG SU; Kao J.-H.
臺大學術典藏 2021-03-09T01:47:37Z Sorafenib and its derivative SC-1 exhibit antifibrotic effects through signal transducer and activator of transcription 3 inhibition TUNG-HUNG SU; Shiau C.-W.; Jao P.; Liu C.-H.; Liu C.-J.; Tai W.-T.; Jeng Y.-M.; Yang H.-C.; Tseng T.-C.; Huang H.-P.; Cheng H.-R.; Chen P.-J.; Chen K.-F.; Kao J.-H.; Chen D.-S.
臺大學術典藏 2021-03-09T01:47:37Z Comparison of abbott realtime HCV genotype II with versant line probe assay 2.0 for hepatitis C virus genotyping Liu C.-H.; Liang C.-C.; Liu C.-J.; Lin C.-L.; TUNG-HUNG SU; Yang H.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-03-09T01:47:37Z Higher lifetime chance of spontaneous surface antigen loss in hepatitis B carriers with genotype C infection Tseng T.-C.; Liu C.-J.; Chen C.-L.; Yang W.-T.; Yang H.-C.; TUNG-HUNG SU; Wang C.-C.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-03-09T01:47:37Z Advanced hepatic fibrosis and steatosis are associated with persistent alanine aminotransferase elevation in chronic hepatitis C patients negative for hepatitis C virus RNA during pegylated interferon plus ribavirin therapy Liang C.-C.; Liu C.-H.; Chung C.-S.; Lin C.-K.; TUNG-HUNG SU; Yang H.-C.; Liu C.-J.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-03-09T01:47:36Z Efficacy of maternal tenofovir disoproxil fumarate in interrupting mother-to-infant transmission of hepatitis B virus Chen H.-L.; Lee C.-N.; Chang C.-H.; Ni Y.-H.; Shyu M.-K.; Chen S.-M.; Hu J.-J.; Lin H.H.; Zhao L.-L.; Mu S.-C.; Lai M.-W.; Lee C.-L.; Lin H.-M.; Tsai M.-S.; Hsu J.-J.; Chen D.-S.; Chan K.A.; Chang M.-H.; Su Y.-N.; Shih J.-C.; Chao K.-H.; Wu J.-F.; Hsu H.-Y.; Liu C.-J.; TUNG-HUNG SU; Lin C.-C.; Lin P.-Y.; Yang W.-R.; Yang C.-K.; Chang Y.-K.; Chen K.-H.; Lin Y.-H.; Chen H.-J.; Pan H.-S.; Lau B.-H.; Cheng P.-J.; Chang Y.-L.; Chiueh H.-Y.; Wang T.-H.; Lo L.-M.; Hsieh C.-L.; Cheng S.-W.; Lin L.-H.; She B.-Q.; Koh K.-J.; Hung Y.-L.; Peng F.-S.; Lin Y.-C.; Wu T.-C.; Chen C.-Y.; Chen C.-P.; Huang J.-P.; Yeung C.-Y.; Lin C.-J.; Chiu W.-T.; Wang D.-S.; Lin W.-T.; Hwang K.-S.; Huang C.-F.; Taiwan Study Group for the Prevention of Mother-to-Infant Transmission of HBV (PreMIT Study)
臺大學術典藏 2021-03-09T01:47:36Z Peginterferon plus weight-based ribavirin for treatment-naïve hepatitis C virus genotype 2 patients not achieving rapid virologic response: A randomized trial Liu C.-H.; Huang C.-F.; Liu C.-J.; Dai C.-Y.; Huang J.-F.; Lin J.-W.; Liang C.-C.; Yang S.-S.; Lin C.-L.; TUNG-HUNG SU; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; Kao J.-H.; Yu M.-L.
臺大學術典藏 2021-03-09T01:47:35Z Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: A randomised trial Liu C.-H.; Liu C.-J.; Huang C.-F.; Lin J.-W.; Dai C.-Y.; Liang C.-C.; Huang J.-F.; Hung P.-H.; Tsai H.-B.; Tsai M.-K.; Lee C.-Y.; Chen S.-I.; Yang S.-S.; TUNG-HUNG SU; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; Yu M.-L.; Kao J.-H.
臺大學術典藏 2021-03-09T01:47:35Z Peginterferon alfa-2a plus Weight-Based or Flat-Dose Ribavirin for Treatment-Naïve Hepatitis C Virus Genotype 2 Rapid Responders: A Randomized Trial Liu C.-H.; Huang C.-F.; Liu C.-J.; Dai C.-Y.; Huang J.-F.; Lin J.-W.; Liang C.-C.; Yang S.-S.; Lin C.-L.; TUNG-HUNG SU; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; Kao J.-H.; Yu M.-L.
臺大學術典藏 2021-03-09T01:47:35Z Higher proportion of viral basal core promoter mutant increases the risk of liver cirrhosis in hepatitis B carriers Tseng T.-C.; Liu C.-J.; Yang H.-C.; Chen C.-L.; Yang W.-T.; Tsai C.-S.; Kuo S.F.-T.; Verbree F.C.; TUNG-HUNG SU; Wang C.-C.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-03-09T01:47:34Z Peginterferon plus Ribavirin for HIV-infected Patients with Treatment-Naive Acute or Chronic HCV Infection in Taiwan: A Prospective Cohort Study Liu C.-H.; Sheng W.-H.; Sun H.-Y.; Hsieh S.-M.; Lo Y.-C.; Liu C.-J.; TUNG-HUNG SU; Yang H.-C.; Liu W.-C.; Chen P.-J.; Chen D.-S.; Hung C.-C.; Kao J.-H.
臺大學術典藏 2021-03-09T01:47:34Z Hepatitis C viral infection increases the risk of lymphoid-neoplasms: A population-based cohort study TUNG-HUNG SU; Liu C.-J.; Tseng T.-C.; Chou S.-W.; Liu C.-H.; Yang H.-C.; Wu S.-J.; Chen P.-J.; Chen D.-S.; Chen C.-L.; Kao J.-H.
臺大學術典藏 2021-03-09T01:47:33Z Hepatitis B surface antigen loss and hepatocellular carcinoma development in patients with dual hepatitis B and C infection Yang W.-T.; Wu L.-W.; Tseng T.-C.; Chen C.-L.; Yang H.-C.; TUNG-HUNG SU; Wang C.-C.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Liu C.-J.; Kao J.-H.
臺大學術典藏 2021-03-09T01:47:33Z Efficacy and resistance to telbivudine treatment in chronic hepatitis B patients with favorable predictors: a multicenter study in Taiwan Wang C.-C.; Lin C.-L.; Hsieh T.-Y.; Tseng K.-C.; Peng C.-Y.; TUNG-HUNG SU; Yang S.-S.; Hsu Y.-C.; Chen T.-M.; Kao J.-H.
臺大學術典藏 2021-03-09T01:47:32Z Hyperglycemia combined Helicobacter pylori infection increases risk of synchronous colorectal adenoma and carotid artery plaque Hu K.-C.; Wu M.-S.; Chu C.-H.; Wang H.-Y.; Lin S.-C.; Po H.L.; Bair M.-J.; Liu C.-C.; TUNG-HUNG SU; Chen C.-L.; Liu C.-J.; Shih S.-C.
臺大學術典藏 2021-03-09T01:47:32Z Associated factors and clinical implications of serum aminotransferase elevation in scrub typhus TUNG-HUNG SU; Liu C.-J.; Shu P.-Y.; Fu Y.-H.; Chang C.-H.; Jao P.; Kao J.-H.
臺大學術典藏 2021-03-09T01:47:32Z Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients TUNG-HUNG SU; Hu T.-H.; Chen C.-Y.; Huang Y.-H.; Chuang W.-L.; Lin C.-C.; Wang C.-C.; Su W.-W.; Chen M.-Y.; Peng C.-Y.; Chien R.-N.; Huang Y.-W.; Wang H.-Y.; Lin C.-L.; Yang S.-S.; Chen T.-M.; Mo L.-R.; Hsu S.-J.; Tseng K.-C.; Hsieh T.-Y.; Suk F.-M.; Hu C.-T.; Bair M.-J.; Liang C.-C.; Lei Y.-C.; Tseng T.-C.; Chen C.-L.; Kao J.-H.; the C-TEAM study group; the Taiwan Liver Diseases Consortium
臺大學術典藏 2021-03-09T01:47:31Z Unmet Needs in Clinical and Basic Hepatitis B Virus Research TUNG-HUNG SU; Kao J.-H.
臺大學術典藏 2021-03-09T01:47:31Z High serum lipopolysaccharide-binding protein level in chronic hepatitis C viral infection is reduced by anti-viral treatments Nien H.-C.; Hsu S.-J.; TUNG-HUNG SU; Yang P.-J.; Sheu J.-C.; Wang J.-T.; Chow L.-P.; Chen C.-L.; Kao J.-H.; Yang W.-S.
臺大學術典藏 2021-03-09T01:47:31Z letter: HBsAg kinetics-guided interferon therapy for chronic hepatitis D Kao C.-N.; TUNG-HUNG SU; Kao J.-H.
臺大學術典藏 2021-03-09T01:47:30Z Response to Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in?chronic hepatitis B patients TUNG-HUNG SU; Kao J.-H.
臺大學術典藏 2021-03-09T01:47:30Z Surveillance of hepatocellular carcinoma by magnetic resonance imaging with liver-specific contrast TUNG-HUNG SU; Kao J.-H.
臺大學術典藏 2021-03-09T01:47:30Z Impact of occult hepatitis B on the clinical outcomes of patients with chronic hepatitis C virus infection: A 10-year follow-up Chen H.-Y.; TUNG-HUNG SU; Tseng T.-C.; Yang W.-T.; Chen T.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H.; Liu C.-J.
臺大學術典藏 2021-03-09T01:47:29Z Combination therapy for chronic hepatitis B: Current updates and perspectives TUNG-HUNG SU; Liu C.-J.

显示项目 31-80 / 193 (共4页)
1 2 3 4 > >>
每页显示[10|25|50]项目